Shop
Cart Details

Triumeq® Abacavir Sulfate / Dolutegravir Sodium / Lamivudine 600 Mg - 50 Mg - 30 Mg Tablet Bottle 30 Tablets

  • Manufacturer Name : VIIV HEALTHCARE
  • MFG # : 49702023113
  • NDC : 49702023113
  • Distributor Name : Cardinal - SAGEBRUSH
PID UOM Price Qty

You are not eligible to purchase this product. Please contact your account manager for more information.

Register For Member Price

 

Additional Information

Product NameTriumeq® Abacavir Sulfate / Dolutegravir Sodium / Lamivudine 600 Mg - 50 Mg - 30 Mg Tablet Bottle 30 Tablets
ApplicationHIV Treatment - Antiretroviral Therapy (ART)
Generic Drug NameAbacavir Sulfate / Dolutegravir Sodium / Lamivudine
Mechanism of ActionAbacavir and Lamivudine inhibit reverse transcriptase, while Dolutegravir inhibits HIV integrase.
Strength600 mg - 50 mg - 30 mg
AdministrationOral, once daily with or without food
Side EffectsHeadache, nausea, diarrhea, fatigue, insomnia, liver enzyme abnormalities, hypersensitivity reactions
PrecautionsMonitor for hypersensitivity reactions, liver function, and HIV resistance during treatment
Drug InteractionsMay interact with other antiretrovirals, rifampin, and drugs affecting CYP450 enzymes
Pregnancy CategoryCategory C (Risk cannot be ruled out)
Container TypeBottle
Quantity30 Tablets
IndicationsHIV-1 infection treatment in adults and pediatric patients (= 40 kg body weight)

Description

Triumeq® is a fixed-dose combination tablet containing abacavir sulfate, dolutegravir sodium, and lamivudine. This formulation combines three antiretroviral agents to treat human immunodeficiency virus type 1 (HIV-1) infection in adults and pediatric patients weighing at least 40 kg. Abacavir is a nucleoside reverse transcriptase inhibitor (NRTI), lamivudine is also an NRTI, and dolutegravir is an integrase strand transfer inhibitor (INSTI).

Abacavir and lamivudine inhibit reverse transcriptase, blocking the conversion of viral RNA into DNA, while dolutegravir inhibits integrase, preventing the integration of viral DNA into the host genome. This combination therapy helps to reduce the viral load, increase CD4 cell counts, and maintain virologic suppression in patients with HIV-1.

Each tablet is administered orally once daily, with or without food. Triumeq® is prescribed as part of a comprehensive treatment regimen for HIV-1 and offers the convenience of a single, once-daily tablet, improving patient adherence to the treatment plan. Common side effects include headache, diarrhea, and fatigue.

Frequently Asked Questions(FAQs)

The cost of Triumeq® Abacavir Sulfate / Dolutegravir Sodium / Lamivudine 600 Mg - 50 Mg - 30 Mg Tablet Bottle 30 Tablets is available for registerd members only .
Triumeq® Abacavir Sulfate / Dolutegravir Sodium / Lamivudine 600 Mg - 50 Mg - 30 Mg Tablet Bottle 30 Tablets is manufactured by VIIV HEALTHCARE.
Read More

Subscribe to Our Newsletter